We will monitor the rule’s implementation and serve as an educational resource for members on its provisions and the impact they will have on rheumatology. For further information about the ACR’s regulatory advocacy efforts, ACR/ARP members should email the ACR’s advocacy team at [email protected]. ACR/ARP members can also schedule a time to meet directly with the ACR’s advocacy team to discuss issues and challenges you are facing.